Sanalitro supports HB3454 to revise epinephrine device guidelines; Illinois House approves 116-0

Rep. Jennifer Sanalitro (R-48th) supported HB3454 during the 104th General Assembly on May 31, 2026, with a Yes vote. According to the Illinois House, the legislation updating requirements for epinephrine devices passed in a 116-0 vote.

The official bill summary identifies the measure as "EPINEPHRINE DELIVERY DEVICE."

The following overview interprets the original text of the bill and may provide clarification of its specific provisions.

HB3454 amends several Illinois laws by replacing terms such as "epinephrine auto-injector" and "epinephrine injector" with "FDA approved epinephrine delivery device or product." The legislation renames the Epinephrine Injector Act as the FDA Approved Epinephrine Delivery Device or Product Act. New policies outlined in the bill address training, authorization, and liability protections for law enforcement and school staff who carry or use these devices for anaphylactic emergencies. Establishments will also need official protocols for procurement, storage, and application of epinephrine delivery devices. The measure requires reporting any uses of these devices to the State Board of Education and establishes rules on funding and training costs. It also mandates that health insurance policies provide coverage for these products for minors, and the changes affect public health and emergency preparedness statutes.

The bill’s final recorded legislative step was 'Senate Floor Amendment No. 2 House Concurs.'

A Republican, Sanalitro began representing the 48th House District in Illinois in 2023, succeeding predecessor Terra Costa Howard.

Bills in Illinois are subject to a multi-step legislative process, beginning with either chamber's introduction, followed by committee consideration, debate, votes in both houses, and final action by the governor. Each biennial session of the General Assembly draws thousands of bill proposals, though only a portion are enacted.